BioNTech drug shows doubled survival in lung cancer trial

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/21/2026

1. SPY
2. WBD
3. PSKY
4. NVDA
5. TSLA
6. USO
7. AMD
8. META
9. AMC
10. COHR

Go back to BioNTech drug shows doubled survival in lung cancer trial
(NASDAQ: BNTX) Delayed: 98.00 +1.94 (2.02%)
Previous Close $96.06    52 Week High $ 
Open $97.25    52 Week Low $ 
Day High $98.98    P/E N/A 
Day Low $96.61    EPS $ 
Volume 800,850